{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:53:10Z","timestamp":1789365190767,"version":"build-2803163510"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1995","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T23:26:30Z","timestamp":1406849190000},"page":"1693-1698","source":"Crossref","is-referenced-by-count":3,"title":["Recurrent &lt;i&gt;Stenotrophomonas maltophilia&lt;\/i&gt; Bacteremia after Iliac Crest Bone Graft Harvest"],"prefix":"10.2169","volume":"53","author":[{"given":"Hideharu","family":"Hagiya","sequence":"first","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Ishida","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Okayama University Medical School, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terasaka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Waseda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Hanayama","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Horita","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Shimamura","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisei","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with <i>Stenotrophomonas maltophilia<\/i>. Clin Microbiol Rev 11: 57-80, 1998.","DOI":"10.1128\/CMR.11.1.57"},{"key":"2","unstructured":"2. Sakhnini E, Weissmann A, Oren I. Fulminant <i>Stenotrophomonas maltophilia<\/i> soft tissue infection in immunocompromised patients: an outbreak transmitted via tap water. Am J Med Sci 323: 269-272, 2002."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Garci&aacute; de Viedma D, Mar&iacute;n M, Cercenado E, Alonso R, Rodr&iacute;guez-Cr&eacute;ixems M, Bouza E. Evidence of nosocomial <i>Stenotrophomonas maltophilia<\/i> cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol 20: 816-820, 1999.","DOI":"10.1086\/501590"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001). Int J Antimicrob Agents 22: 551-556, 2003.","DOI":"10.1016\/S0924-8579(03)00245-0"},{"key":"5","unstructured":"5. Brooke JS. <i>Stenotrophomonas maltophilia<\/i>: an emerging global opportunistic pathogen. Clin Microbiol Rev 25: 2-41, 2012."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Heath T, Currie B. Nosocomial and community-acquired <i>Xanthomonas maltophilia<\/i> infection in tropical Australia. J Hosp Infect 30: 309-313, 1995.","DOI":"10.1016\/0195-6701(95)90266-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gilardi GL. <i>Pseudomonas maltophilia<\/i> infections in man. Am J Clin Pathol 51: 58-61, 1969.","DOI":"10.1093\/ajcp\/51.1.58"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gilardi GL. Characterization of nonfermentative nonfastidious gram negative bacteria encountered in medical bacteriology. J Appl Bacteriol 34: 623-644, 1971.","DOI":"10.1111\/j.1365-2672.1971.tb02326.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Baltimore RS, Jenson HB. Puncture wound osteochondritis of the foot caused by <i>Pseudomonas maltophilia<\/i>. Pediatr Infect Dis J 9: 143-144, 1990.","DOI":"10.1097\/00006454-199002000-00017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Trumbore D, Pontzer R, Levison ME, et al. Multicenter study of the clinical efficacy of imipenem\/cilastatin for treatment of serious infections. Rev Infect Dis 7 (Suppl 3): S476-S481, 1985.","DOI":"10.1093\/clinids\/7.Supplement_3.S476"},{"key":"11","unstructured":"11. Agger WA, Cogbill TH, Busch H Jr, Landercasper J, Callister SM. Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli. Rev Infect Dis 8: 927-931, 1986."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Landrum ML, Conger NG, Forgione MA. Trimethoprim-sulfamethoxazole in the treatment of <i>Stenotrophomonas maltophilia<\/i> osteomyelitis. Clin Infect Dis 40: 1551-1552, 2005.","DOI":"10.1086\/429730"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. German V, Tsimpoukas F, Goritsas C, Ferti A. Spondylodiscitis due to <i>Stenotrophomonas maltophilia<\/i>. Eur J Intern Med 18: 501-503, 2007.","DOI":"10.1016\/j.ejim.2007.02.016"},{"key":"14","unstructured":"14. Gulmez D, Hascelik G. <i>Stenotrophomonas maltophilia<\/i>: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect 11: 880-886, 2005."},{"key":"15","unstructured":"15. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteraemia due to <i>Stenotrophomonas maltophilia<\/i>: an analysis of 45 episodes. J Infect 45: 47-53, 2002."},{"key":"16","unstructured":"16. Jang TN, Wang FD, Wang LS, Liu CY, Liu IM. <i>Xanthomonas maltophilia<\/i> bacteremia: an analysis of 32 cases. J Formos Med Assoc 91: 1170-1176, 1992."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Victor MA, Arpi M, Bruun B, J&oslash;nsson V, Hansen MM. <i>Xanthomonas maltophilia<\/i> bacteremia in immunocompromised hematological patients. Scand J Infect Dis 26: 163-170, 1994.","DOI":"10.3109\/00365549409011780"},{"key":"18","unstructured":"18. Calza L, Manfredi R, Chiodo F. <i>Stenotrophomonas (Xanthomonas) maltophilia<\/i> as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection 31: 155-161, 2003."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Metan G, Hayran M, Hascelik G, Uzun O. Which patient is a candidate for empirical therapy against <i>Stenotrophomonas maltophilia<\/i> bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis 38: 527-531, 2006.","DOI":"10.1080\/00365540500452481"},{"key":"20","unstructured":"20. Apisarnthanarak A, Mayfield JL, Garison T, et al. Risk factors for <i>Stenotrophomonas maltophilia<\/i> bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24: 269-274, 2003."},{"key":"21","unstructured":"21. Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with <i>Stenotrophomonas maltophilia<\/i> bacteremia. J Microbiol Immunol Infect 37: 350-358, 2004."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Caylan R, Kaklikkaya N, Aydin K, et al. An epidemiological analysis of <i>Stenotrophomonas maltophilia<\/i> strains in a university hospital. Jpn J Infect Dis 57: 37-40, 2004.","DOI":"10.7883\/yoken.JJID.2004.37"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chatelut M, Dournes JL, Chabanon G, Marty N. Epidemiological typing of <i>Stenotrophomonas (Xanthomonas) maltophilia<\/i> by PCR. J Clin Microbiol 33: 912-914, 1995.","DOI":"10.1128\/JCM.33.4.912-914.1995"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Barbier-Frebour N, Boutiba-Boubake I, Nouvello M, Lemelan J. Molecular investigation of <i>Stenotrophomonas maltophilia<\/i> isolates exhibiting rapid emergence of ticarcillin-clavulanate resistance. J Hosp Infect 45: 35-41, 2000.","DOI":"10.1053\/jhin.1999.0708"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Foley SL, Lynne AM, Nayak R. Molecular typing methodologies for microbial source tracking and epidemiological investigations of Gram-negative bacterial foodborne pathogens. Infect Genet Evol 9: 430-440, 2009.","DOI":"10.1016\/j.meegid.2009.03.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sattler CA, Mason EO Jr, Kaplan SL. Nonrespiratory <i>Stenotrophomonas maltophilia<\/i> infection at a children's hospital. Clin Infect Dis 31: 1321-1330, 2000.","DOI":"10.1086\/317473"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Muder RR. Optimizing therapy for <i>Stenotrophomonas maltophilia<\/i>. Semin Respir Crit Care Med 28: 672-677, 2007.","DOI":"10.1055\/s-2007-996414"},{"key":"28","unstructured":"28. Garrison MW, Anderson DE, Campbell DM, et al. <i>Stenotrophomonas maltophilia<\/i>: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother 40: 2859-2864, 1996."},{"key":"29","unstructured":"29. Al-Jasser AM. <i>Stenotrophomonas maltophilia<\/i> resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob 5: 23, 2006."},{"key":"30","unstructured":"30. Muder RR, Harris AP, Muller S, et al. Bacteremia due to <i>Stenotrophomonas (Xanthomonas) maltophilia<\/i>: a prospective, multicenter study of 91 episodes. Clin Infect Dis 22: 508-512, 1996."},{"key":"31","unstructured":"31. Falagas ME, Valkimadi PE, Huang YT, Matthaiou DK, Hsueh PR. Therapeutic options for <i>Stenotrophomonas maltophilia<\/i> infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother 62: 889-894, 2008."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bonfiglio G, Cascone C, Azzarelli C, Cafiso V, Marchetti F, Stefani S. Levofloxacin <i>in vitro<\/i> activity and time-kill evaluation of <i>Stenotrophomonas maltophilia<\/i> clinical isolates. J Antimicrob Chemother 45: 115-117, 2000.","DOI":"10.1093\/jac\/45.1.115"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Weiss K, Restieri C, De Carolis E, Laverdi&egrave;re M, Guay H. Comparative activity of new quinolones against 326 clinical isolates of <i>Stenotrophomonas maltophilia<\/i>. J Antimicrob Chemother 45: 363-365, 2000.","DOI":"10.1093\/jac\/45.3.363"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Akova M, Bonfiglio G, Livermore DM. Susceptibility to &beta;-lactam antibiotics of mutant strains of <i>Xanthomonas maltophilia<\/i> with high- and low-level constitutive expression of L1 and L2 &beta;-lactamases. J Med Microbiol 35: 208-213, 1991.","DOI":"10.1099\/00222615-35-4-208"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Lecso-Bornet M, Pierre J, Sarkis-Karam D, Lubera S, Bergogne-Berezin E. Susceptibility of <i>Xanthomonas maltophilia<\/i> to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob Agents Chemother 36: 669-671, 1992.","DOI":"10.1128\/AAC.36.3.669"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/15\/53_53.1995\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:23:25Z","timestamp":1746321805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/15\/53_53.1995\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1995","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}